BIOSENSE WEBSTER INC EZ STEER NAV DS BI-DIRECTIONAL ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
|
Back to Search Results |
|
Model Number BN7TCDD8L |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Arrest (1762)
|
Event Date 08/04/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a (b)(6) male patient ((b)(6)) underwent an atrial flutter right (r-afl) ablation procedure with ez steer" nav bi-directional electrophysiology catheter and suffered cardiac arrest requiring cpr, defibrillator and medication.During an atrial flutter right sided, on (b)(6) 2021 at approximately 1p the patient coded.The patient did not have a pulse and it was confirmed by the recording system and by the physician.The patient received cpr and medication (unknown type) and the pulse was restored, and the blood pressure restored to normal range as well.No ablation had occurred, and they were preforming entrainment mapping when the issue occurred.The patient was reported to be in stable condition.The adverse event was discovered while ez steer" nav ds bi-directional electrophysiology catheter was in the right atrium (ablator) and coronary sinus (webster ¿ cs catheter with ez steer" technology).No ablation had occurred prior to the event.The physicians opinion on the cause of this adverse is that this is patient condition related.The ef was low to begin with, and the physician was not positive on what happened but referred to it as a transient asystole.Code team intervention was required, and cpr was administered, defibrillator used.The patient outcome of the adverse event was reported as fully recovered (no residual effects).It is unknown if the patient required extended hospitalization because of the adverse event.
|
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4) during an internal review on 31-aug-2021, it was noticed that the physician¿s name and reporter state were inadvertently left out on the initial report.Therefore, e 1.Initial reporter title, e 1.Initial reporter first name, e 1.Initial reporter last name, and e1.Initial reporter state were updated.
|
|
Search Alerts/Recalls
|
|
|